TABLE 2. PATENTS ASSOCIATED WITH ATHENA’S COMPLETE ATAXIA PANEL.
Genetic Test |
US Patents | Assignee |
---|---|---|
SCA-1 | 5741645, 5834183 | Regents of the University of Minnesota, Minneapolis, MN |
SCA-2 | 6251589 | SRL, Inc., Tachikawa, Japan |
SCA-3 | 5840491 | Akira Kakizuka, Kyoto, Japan |
SCA-6 | 5853995, 6303307, 7329487 |
Research Development Foundation, Carson City, NV |
SCA-7 | 6280938, 6514755, 7118893 |
Regents of the University of Minnesota, Minneapolis, MN |
SCA-8 | 6524791 | Regents of the University of Minnesota, Minneapolis, MN |
SCA-10 | 6855497 | Baylor College of Medicine, Houston, TX |
Friedrichs Ataxia (Frataxin) |
6150091 | Baylor College of Medicine, Houston, TX, INSERM, Paris, France |
Aprataxin | 7119186 | Athena Diagnostics, Inc., Worcester, MA |
Athena Diagnostics controls 11 patents (in bold) for 6 tests for hereditary ataxia by exclusive licenses. It also holds a non-exclusive license to US6855497 for SCA-10 testing. Additional patents for SCA-2 (US6623927, US6673535 and US6844431) were found in our search that Athena does not appear to have licensed.